EUCTR2017-001132-19-DK进行中（未招募）1 期
Effects of Metformin on portal hypertension in patients with cirrhosis.
Aarhus University Hospital0 个研究点目标入组 44 人开始时间: 2017年4月21日最近更新:
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 44
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •-age> 18 years
- •-diagnosed with cirrhosis
- •-informed consent
- •-clinical indication for liver vein catherisation (LVC) and/or transjugular
- •intrahepatic portosystemic shunt (TIPS)
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range 44
- •F.1.3 Elderly (>=65 years) no
- •F.1.3.1 Number of subjects for this age range 0
排除标准
- •servere liver disease (Child Pugh class 12-15)
- •incable to understand or read Danish
- •side effects og allergies to Metformin
研究者
相似试验
招募中
2 期
Effects of Metformin on Hepatic Venous Pressure Gradient in Patients With Cirrhosis and Portal HypertensionPortal Hypertension Related to CirrhosisCirrhosisNCT06687265Assistance Publique - Hôpitaux de Paris76
招募中
2 期
Therapeutic effect of metformin in rectal cancerRectal cancer.Malignant neoplasm of rectumIRCT20190726044335N1Shiraz University of Medical Sciences90
已完成
不适用
Effect of Metformin (Drug)in Patients With Cryptogenic Cirrhosis (Liver Disease) With DiabetesCTRI/2018/03/012814Institute of liver and Biliary Sciences86
招募中
4 期
Investigating the effect of metformin on vascular function and cardiovascular risk factors in children and adolescents with type 1 diabetesType 1 diabetes mellitusIRCT20230930059564N1Shahid Beheshti University of Medical Sciences52
已完成
不适用
The effects of metformin on vascular function and adipocyte AMP-activated protein kinase (AMPK) activation in type 2 diabetesISRCTN51336867Greater Glasgow Health Board (North Glasgow University Hospitals Division) (UK)20